Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.15.0 to v2.15.2 and has changed the date from April 6, 2025, to April 30, 2025.
    Difference
    0.6%
    Check dated 2025-04-30T13:49:45.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T01:46:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has updated the date for results from November 19, 2024, to April 6, 2025, and has changed the status from 'Results Submitted' to 'Results Posted'.
    Difference
    2%
    Check dated 2025-04-08T20:28:37.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T18:25:14.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page has been updated to indicate that results have been submitted, replacing the previous status of no results posted.
    Difference
    0.5%
    Check dated 2025-02-17T12:50:23.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    5%
    Check dated 2025-02-10T09:18:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.